Product
Bradykinin
1 clinical trial
1 indication
Indication
HypertensionClinical trial
Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1Status: Active (not recruiting), Estimated PCD: 2025-07-01
1 clinical trial
1 indication